Estrace (Estradiol Vaginal) - Adverse Event Reports - Death

Breast Cancer (2),  Breast Cancer Female (2),  Breast Cancer Metastatic (2),  Ovarian Cancer Metastatic (1),  Mass (1),  Nipple Pain (1),  Vaginal Disorder (1)

Adverse event in female receiving Estrace (Estradiol Vaginal)

Reported by a consumer/non-health professional from United States on 2007-10-31

Patient: female, weighing 79.5 kg (174.8 pounds)

Adverse reactions / side effects: Ovarian Cancer Metastatic

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Estrace

Estradiol
    Dosage: unknown
    Administration route: Oral
    Indication: Menopausal Symptoms Prophylaxis
    Start date: 1989-01-01

Estrogens Esterified / Methyltestosterone

Premarin
    Dosage: unspecified
    Administration route: Oral
    Start date: 1992-01-01
    End date: 2004-01-01

Other drugs received by patient: Xanax

Adverse event in 61 year old female receiving Estrace (Estradiol Vaginal)

Reported by a pharmacist from United States on 2007-10-05

Patient: 61 year old female

Adverse reactions / side effects: Mass, Nipple Pain, Vaginal Disorder

Adverse event resulted in: death

Suspect drug(s):
Estrace (Estradiol Vaginal)

Adverse event in female receiving Estrace (Estradiol Vaginal)

Reported by a lawyer from United States on 2007-07-31

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Adverse event resulted in: death

Suspect drug(s):
Estrace
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2000-01-01

Estratest
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2000-01-01

Premarin
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2000-01-01

Provera
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2000-01-01

Adverse event in female receiving Estrace (Estradiol Vaginal)

Reported by a consumer/non-health professional from United States on 2007-03-09

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: death

Suspect drug(s):
Estrace
    Indication: Hormone Replacement Therapy

Premarin
    Indication: Oestrogen Replacement Therapy

Adverse event in female receiving Estrace (Estradiol Vaginal)

Reported by a lawyer from United States on 2007-03-07

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic, Breast Cancer Female

Adverse event resulted in: death

Suspect drug(s):
Estrace
    Dosage: oral
    Administration route: Oral
    Start date: 1985-01-01
    End date: 1999-01-01

Estradiol
    Dosage: oral
    Administration route: Oral
    Start date: 1985-01-01
    End date: 1999-01-01

Premarin
    Dosage: oral
    Administration route: Oral
    Start date: 1985-01-01
    End date: 1995-01-01

Adverse event in 59 year old female receiving Estrace (Estradiol Vaginal)

Reported by a consumer/non-health professional from United States on 2007-01-18

Patient: 59 year old female

Adverse reactions / side effects: Breast Cancer, Death

Adverse event resulted in: death

Suspect drug(s):
Estrace
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2004-01-01

Estrace
    Indication: Osteoporosis
    Start date: 1995-01-01
    End date: 2004-01-01

Estradiol
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2004-01-01

Medroxyprogesterone
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2004-01-01

Prometrium
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2004-01-01

Provera
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2004-01-01

Adverse event in 59 year old female receiving Estrace (Estradiol Vaginal)

Reported by a lawyer from United States on 2007-01-12

Patient: 59 year old female

Adverse reactions / side effects: Breast Cancer

Adverse event resulted in: death

Suspect drug(s):
Estrace
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2004-01-01

Estradiol
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2004-01-01

Medroxyprogesterone
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2004-01-01

Prometrium
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2004-01-01

Provera
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2004-01-01